| Section(X) | Body System(W) | Operation(0) | Approach(3) | Qualifier(3) | Device / Substance / Technology(C) | Body Part(4) |
| New Technology | Anatomical Regions | Introduction | Percutaneous | New Technology Group 3 | Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous | Central Vein |
No record found
| Change Type | Change Date | Previous Descriptor |
| Code Deleted | 09-30-2021 | |
| Code Added | 10-01-2017 |